InvestorsHub Logo
Followers 27
Posts 5124
Boards Moderated 0
Alias Born 01/27/2014

Re: None

Tuesday, 07/06/2021 10:01:09 AM

Tuesday, July 06, 2021 10:01:09 AM

Post# of 30381
“We have received correspondence from the FDA that Part 2 will serve as a registrational study for the SLS-002 program and we will continue discussions with the FDA on the regulatory pathway going forward."

HUGE!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News